相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter
Davide Amato et al.
MOLECULAR PSYCHIATRY (2020)
What proportion of striatal D2 receptors are occupied by endogenous dopamine at baseline? A meta-analysis with implications for understanding antipsychotic occupancy
Fernando Caravaggio et al.
NEUROPHARMACOLOGY (2020)
From bedside to bench and back: A translational approach to studying dopamine dysfunction in schizophrenia
Anissa Abi-Dargham
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study
Yusuke Iwata et al.
BIOLOGICAL PSYCHIATRY (2019)
A Complete Assessment of Dopamine Receptor- Ligand Interactions through Computational Methods
Beatriz Bueschbell et al.
MOLECULES (2019)
The transition to cocaine addiction: the importance of pharmacokinetics for preclinical models
Alex B. Kawa et al.
PSYCHOPHARMACOLOGY (2019)
Thinking About Schizophrenia in an Era of Genomic Medicine
Daniel R. Weinberger
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophrenia
Hiroyoshi Takeuchi et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia
John M. Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2019)
Effects of Amphetamine on Sensorimotor Gating and Neurocognition in Antipsychotic-Medicated Schizophrenia Patients
Neal R. Swerdlow et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Is it Pre- or Postsynaptic? Imaging Striatal Dopamine Excess in Schizophrenia
Mark Slifstein et al.
BIOLOGICAL PSYCHIATRY (2018)
Dopamine, the antipsychotic molecule: A perspective on mechanisms underlying antipsychotic response variability
Davide Amato et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
What causes psychosis? An umbrella review of risk and protective factors
Joaquim Radua et al.
WORLD PSYCHIATRY (2018)
Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment
Diego Scheggia et al.
NATURE COMMUNICATIONS (2018)
Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects
Jie Yuan et al.
ADDICTION BIOLOGY (2017)
Capturing schizophrenia-like prodromal symptoms in a spinocerebellar ataxia-17 transgenic rat
Davide Amato et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free Conditions
Daniel Paul Eisenberg et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Neuroadaptations to antipsychotic drugs: Insights from pre-clinical and human post-mortem studies
Davide Amato et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Availability of dopamine transporters in heroin-dependent subjects: A 18F-FECNT PET imaging study
Shasha Xu et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2017)
Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
A. Demjaha et al.
PSYCHOLOGICAL MEDICINE (2017)
Cocaine-induced adaptation of dopamine D2S, but not D2L autoreceptors
Brooks G. Robinson et al.
ELIFE (2017)
Dopamine Transporter Availability in Clinically Normal Aging Is Associated With Individual Differences in White Matter Integrity
Anna Rieckmann et al.
HUMAN BRAIN MAPPING (2016)
Social Stress and Psychosis Risk: Common Neurochemical Substrates?
Romina Mizrahi
NEUROPSYCHOPHARMACOLOGY (2016)
Regulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice
Michael F. Salvatore et al.
ACS CHEMICAL NEUROSCIENCE (2016)
The fast-off hypothesis revisited: A functional kinetic study of antipsychotic antagonism of the dopamine D2 receptor
Kristoffer Sahlholm et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Catechol-O-Methyltransferase Va1158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis
Eric Huang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Schizophrenia risk from complex variation of complement component 4
Aswin Sekar et al.
NATURE (2016)
Neurobiologic Advances from the Brain Disease Model of Addiction
Nora D. Volkow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Striatal dopamine neurotransmission: Regulation of release and uptake
David Sulzer et al.
BASAL GANGLIA (2016)
Drug use disorders in the polydrug context: new epidemiological evidence from a foodborne outbreak approach
Catalina Lopez-Quintero et al.
ADDICTION REVIEWS 2015 (2015)
Serotonin in antipsychotic drugs action
Davide Amato
BEHAVIOURAL BRAIN RESEARCH (2015)
Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia
Tomotaka Suzuki et al.
PSYCHIATRY RESEARCH (2015)
Distinct regulation of dopamine D2S and D2L autoreceptor signaling by calcium
Stephanie C Gantz et al.
eLife (2015)
Reduced Dopamine Transporter Availability and Neurocognitive Deficits in Male Patients with Alcohol Dependence
Che-Hung Yen et al.
PLOS ONE (2015)
Therapeutic Window for Striatal Dopamine D2/3 Receptor Occupancy in Older Patients with Schizophrenia: A Pilot PET Study
Hiroyuki Uchida et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2014)
Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function
Arsime Demjaha et al.
BIOLOGICAL PSYCHIATRY (2014)
White matter integrity as a predictor of response to treatment in first episode psychosis
Tiago Reis Marques et al.
BRAIN (2014)
Effects of haloperidol on Kv4.3 potassium channels
Hong Joon Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Typical and atypical antipsychotics do not differ markedly in their reversibility of antagonism of the dopamine D2 receptor
Kristoffer Sahlholm et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Radiosynthesis and validation of 18F-FP-CMT, a phenyltropane with superior properties for imaging the dopamine transporter in living brain
Paul Cumming et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)
Dose and Dosing Frequency of Long-Acting Injectable Antipsychotics A Systematic Review of PET and SPECT Data and Clinical Implications
Hiroyuki Uchida et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2014)
Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis
S. V. Faraone et al.
MOLECULAR PSYCHIATRY (2014)
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke et al.
NATURE (2014)
Phasic Dopamine Release Drives Rapid Activation of Striatal D2-Receptors
Pamela F. Marcott et al.
NEURON (2014)
White Matter Changes Associated with Antipsychotic Treatment in First-Episode Psychosis
Philip R. Szeszko et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Prior Antipsychotic Drug Treatment Prevents Response to Novel Antipsychotic Agent in the Methylazoxymethanol Acetate Model of Schizophrenia
Kathryn M. Gill et al.
SCHIZOPHRENIA BULLETIN (2014)
Social Isolation Exacerbates Schizophrenia-Like Phenotypes via Oxidative Stress in Cortical Interneurons
Zhihong Jiang et al.
BIOLOGICAL PSYCHIATRY (2013)
Optimal Extent of Dopamine D2 Receptor Occupancy by Antipsychotics for Treatment of Dopamine Supersensitivity Psychosis and Late-Onset Psychosis
Masaomi Iyo et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Prenatal Stress Induces Schizophrenia-Like Alterations of Serotonin 2A and Metabotropic Glutamate 2 Receptors in the Adult Offspring: Role of Maternal Immune System
Terrell Holloway et al.
JOURNAL OF NEUROSCIENCE (2013)
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Stefan Leucht et al.
LANCET (2013)
Striatal dopamine release in schizophrenia comorbid with substance dependence
J. L. Thompson et al.
MOLECULAR PSYCHIATRY (2013)
Aging magnifies the effects of dopamine transporter and D2 receptor genes on backward serial memory
Shu-Chen Li et al.
NEUROBIOLOGY OF AGING (2013)
Temporal Pattern of Cocaine Intake Determines Tolerance vs Sensitization of Cocaine Effects at the Dopamine Transporter
Erin S. Calipari et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: Correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses
Andrea de Bartolomeis et al.
PSYCHIATRY RESEARCH (2013)
Dopamine transporter availability in heroin-dependent subjects and controls: longitudinal changes during abstinence and the effects of Jitai tablets treatment
Ying Liu et al.
PSYCHOPHARMACOLOGY (2013)
Striatal Presynaptic Dopamine in Schizophrenia, Part I: Meta-Analysis of Dopamine Active Transporter (DAT) Density
Paolo Fusar-Poli et al.
SCHIZOPHRENIA BULLETIN (2013)
The Psychosis High-Risk State A Comprehensive State-of-the-Art Review
Paolo Fusar-Poli et al.
JAMA PSYCHIATRY (2013)
Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study
Claire Leroy et al.
ADDICTION BIOLOGY (2012)
Dual Control of Dopamine Synthesis and Release by Presynaptic and Postsynaptic Dopamine D2 Receptors
Andrea Anzalone et al.
JOURNAL OF NEUROSCIENCE (2012)
Use-Dependent Inhibition of Synaptic Transmission by the Secretion of Intravesicularly Accumulated Antipsychotic Drugs
Carsten H. Tischbirek et al.
NEURON (2012)
Cocaine Self-Administration Produces Pharmacodynamic Tolerance: Differential Effects on the Potency of Dopamine Transporter Blockers, Releasers, and Methylphenidate
Mark J. Ferris et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patients
Paul Fallon et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2012)
Drugs as instruments: A new framework for non-addictive psychoactive drug use
Christian P. Mueller et al.
BEHAVIORAL AND BRAIN SCIENCES (2011)
Antipsychotic Occupancy of Dopamine Receptors in Schizophrenia
Magdalena Nord et al.
CNS NEUROSCIENCE & THERAPEUTICS (2011)
Dynamic regulation of dopamine and serotonin responses to salient stimuli during chronic haloperidol treatment
Davide Amato et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Regulation of dopaminergic neuron firing by heterogeneous dopamine autoreceptors in the substantia nigra pars compacta
Jin Young Jang et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Maternal Influenza Viral Infection Causes Schizophrenia-Like Alterations of 5-HT2A and mGlu2 Receptors in the Adult Offspring
Jose L. Moreno et al.
JOURNAL OF NEUROSCIENCE (2011)
Continuous, but not Intermittent, Antipsychotic Drug Delivery Intensifies the Pursuit of Reward Cues
Anne-Marie Bedard et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Role of Kv1 Potassium Channels in Regulating Dopamine Release and Presynaptic D2 Receptor Function
Philippe Martel et al.
PLOS ONE (2011)
Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey
Joel Swendsen et al.
ADDICTION (2010)
Dopamine transporter down-regulation following repeated cocaine: implications for 3,4-methylenedioxymethamphetamine-induced acute effects and long-term neurotoxicity in mice
I. Peraile et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
The environment and schizophrenia
Jim van Os et al.
NATURE (2010)
Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia
Mingqing Xu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Dopamine Transporter PET in Normal Aging: Dopamine Transporter Decline and its Possible Role in Preservation of Motor Function
Andre R. Troiano et al.
SYNAPSE (2010)
Signaling pathways in schizophrenia: emerging targets and therapeutic strategies
Caline S. Karam et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia
Alessandro Bertolino et al.
BRAIN (2009)
Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
O. D. Howes et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Effects of the Antipsychotic Risperidone on Dopamine Synthesis in Human Brain Measured by Positron Emission Tomography with L-[β-11C]DOPA: A Stabilizing Effect for Dopaminergic Neurotransmission?
Hiroshi Ito et al.
JOURNAL OF NEUROSCIENCE (2009)
Dopamine and Amphetamine Rapidly Increase Dopamine Transporter Trafficking to the Surface: Live-Cell Imaging Using Total Internal Reflection Fluorescence Microscopy
Cheryse A. Furman et al.
JOURNAL OF NEUROSCIENCE (2009)
Pretreatment with Haloperidol Reduces 123I-FP-CIT Binding to the Dopamine Transporter in the Rat Striatum: An In Vivo Imaging Study with a Dedicated Small-Animal SPECT Camera
Susanne Nikolaus et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
The Dopamine D2 Receptors in High-Affinity State and D3 Receptors in Schizophrenia: A Clinical [11C]-(+)-PHNO PET Study
Ariel Graff-Guerrero et al.
NEUROPSYCHOPHARMACOLOGY (2009)
D2-Receptor Upregulation is Dependent upon Temporal Course of D2-Occupancy: A Longitudinal [11C]-Raclopride PET Study in Cats
Nathalie Ginovart et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Substance Use Disorders in Schizophrenia - Clinical Implications of Comorbidity
Nora D. Volkow
SCHIZOPHRENIA BULLETIN (2009)
Less is more: Antipsychotic drug effects are greater with transient rather than continuous delivery
Anne-Noel Samaha et al.
BIOLOGICAL PSYCHIATRY (2008)
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
Gunnar Morken et al.
BMC PSYCHIATRY (2008)
Role of the Dopamine Transporter in the Action of Psychostimulants, Nicotine, and Other Drugs of Abuse
J. Zhu et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2008)
Age-related changes in dopamine transporters and accumulation of 3-nitrotyrosine in rhesus monkey midbrain dopamine neurons: Relevance in selective neuronal vulnerability to degeneration
N. M. Kanaan et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions
Bruno P. Guiard et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk
K. K. Nicodemus et al.
MOLECULAR PSYCHIATRY (2008)
Differential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics
V. Molina et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
D-2 receptor occupancy of olanzapine pamoate depot using positron emission tomography: An open-label study in patients with schizophrenia
David Mamo et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory
Ying Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics - An integrated analysis
Charles M. Beasley et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Breakthrough dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time
Anne-Noel Samaha et al.
JOURNAL OF NEUROSCIENCE (2007)
Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge
I Vernaleken et al.
NEUROIMAGE (2006)
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment
JP McEvoy et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone
G Remington et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Is there a common molecular pathway for addiction?
EJ Nestler
NATURE NEUROSCIENCE (2005)
Block of delayed-rectifier potassium channels by reduced haloperidol and related compounds in mouse cortical neurons
SB Yang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis
P Seeman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
S Miyamoto et al.
MOLECULAR PSYCHIATRY (2005)
DAncing past the DAT at a DA synapse
SJ Cragg et al.
TRENDS IN NEUROSCIENCES (2004)
Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol
K Håkansson et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Inhibition of ATP-sensitive potassium channels by haloperidol
SB Yang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Rapid regulation of the dopamine transporter: role in stimulant addiction?
NR Zahniser et al.
NEUROPHARMACOLOGY (2004)
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum
D Centonze et al.
NEUROSCIENCE (2004)
Effect of acute antipsychotic administration on dopamine synthesis in rodents and human subjects using 6-[18F]-L-m-tyrosine
D Mamo et al.
SYNAPSE (2004)
Half a century of antipsychotics and still a central role for dopamine D2 receptors
S Kapur et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites
N Lindgren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo
G Gründer et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia
S Kapur
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Plasma membrane monoamine transporters: Structure, regulation and function
GE Torres et al.
NATURE REVIEWS NEUROSCIENCE (2003)
Age-related changes in the striatal dopaminergic system in the living brain: A multiparametric PET study in conscious monkeys
N Harada et al.
SYNAPSE (2002)
Clozapine can induce high dopamine D2 receptor occupancy in vivo
T Suhara et al.
PSYCHOPHARMACOLOGY (2002)
Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice
R Xu et al.
MOLECULAR PSYCHIATRY (2002)
Dopaminergic dysfunction in alcoholism and schizophrenia - psychopathological and behavioral correlates
A Heinz
EUROPEAN PSYCHIATRY (2002)
Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence
ND Volkow et al.
JOURNAL OF NEUROSCIENCE (2001)
Inhibition of dopamine release via presynaptic D2 receptors:: Time course and functional characteristics in vivo
M Benoit-Marand et al.
JOURNAL OF NEUROSCIENCE (2001)
Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo
EH Danielsen et al.
SYNAPSE (2001)
A neurobiological basis for substance abuse comorbidity in schizophrenia
RA Chambers et al.
BIOLOGICAL PSYCHIATRY (2001)
D2 and 5HT2A receptor occupancy of different doses of quetiapine in schizophrenia:: a PET study
O Gefvert et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2001)
Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions
YY Wang et al.
JOURNAL OF NEUROSCIENCE (2000)
Distinct functions of the two isoforms of dopamine D2 receptors
A Usiello et al.
NATURE (2000)
Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans:: a clinical PET study
S Silvestri et al.
PSYCHOPHARMACOLOGY (2000)
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia
A Abi-Dargham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
A positron emission tomography study of quetiapine in schizophrenia -: A preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy
S Kapur et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Substance use disorders in schizophrenia: Review, integration, and a proposed model
JJ Blanchard et al.
CLINICAL PSYCHOLOGY REVIEW (2000)
Relationship between dopamine D2 occupancy, clinical response, and side effects:: A double-blind PET study of first-episode schizophrenia
S Kapur et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Genotype influences in vivo dopamine transporter availability in human striatum
A Heinz et al.
NEUROPSYCHOPHARMACOLOGY (2000)
分享论文
